A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Bio Techne Corp stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 16,347 shares of TECH stock, worth $1.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,347
Previous 16,058 1.8%
Holding current value
$1.2 Million
Previous $1.15 Million 13.57%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$70.96 - $82.35 $20,507 - $23,799
289 Added 1.8%
16,347 $1.31 Million
Q2 2024

Jul 30, 2024

BUY
$62.12 - $84.15 $15,219 - $20,616
245 Added 1.55%
16,058 $1.15 Million
Q1 2024

May 02, 2024

SELL
$65.98 - $77.09 $3,892 - $4,548
-59 Reduced 0.37%
15,813 $1.11 Million
Q3 2023

Oct 30, 2023

BUY
$67.52 - $89.42 $236,455 - $313,148
3,502 Added 28.31%
15,872 $1.08 Million
Q2 2023

Aug 04, 2023

BUY
$73.76 - $85.98 $4,351 - $5,072
59 Added 0.48%
12,370 $1.01 Million
Q1 2023

May 02, 2023

BUY
$71.62 - $86.62 $16,830 - $20,355
235 Added 1.95%
12,311 $913,000
Q4 2022

Jan 26, 2023

BUY
$80.67 - $352.29 $732,967 - $3.2 Million
9,086 Added 303.88%
12,076 $0
Q3 2022

Oct 19, 2022

BUY
$282.54 - $391.85 $7,063 - $9,796
25 Added 0.84%
2,990 $849,000
Q2 2022

Jul 13, 2022

BUY
$322.67 - $449.65 $188,439 - $262,595
584 Added 24.53%
2,965 $1.03 Million
Q1 2022

Apr 19, 2022

SELL
$353.85 - $487.79 $1,415 - $1,951
-4 Reduced 0.17%
2,381 $1.03 Million
Q3 2021

Oct 15, 2021

BUY
$444.87 - $538.88 $112,996 - $136,875
254 Added 11.92%
2,385 $1.16 Million
Q2 2021

Jul 19, 2021

BUY
$387.35 - $450.26 $825,442 - $959,504
2,131 New
2,131 $959,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.